Securities Registration (section 12(b)) (8-a12b)
November 24 2015 - 6:11AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
Thermo Fisher
Scientific Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware |
|
04-2209186 |
(State of incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
81 Wyman Street
Waltham, Massachusetts |
|
02451 |
(Address of principal executive offices) |
|
(Zip Code) |
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class
to be so registered |
|
Name of each exchange on which
each class is to be registered |
1.500% Notes due 2020 |
|
New York Stock Exchange LLC |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. x
If this form relates to the registration of
a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨
Securities Act registration statement file number to which this form relates: 333-187080 (If applicable)
Securities to be registered pursuant to Section 12(g) of the Act: None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
Thermo Fisher Scientific Inc. (the Company) has filed with the Securities and Exchange Commission (the SEC) a
registration statement on Form S-3 (File No. 333-187080) under the Securities Act of 1933, as amended (the Securities Act), and a prospectus dated March 6, 2013 (the Base Prospectus), as supplemented
by a prospectus supplement dated November 13, 2015 (the Prospectus Supplement), filed pursuant to Rule 424(b) under the Securities Act, relating to the securities to be registered hereunder. The Company incorporates by
reference the Base Prospectus and Prospectus Supplement to the extent set forth below.
Item 1. |
Description of Registrants Securities to be Registered. |
The information required by this item is
incorporated by reference to the information contained in the sections captioned Description of the Notes and Certain Material U.S. Federal Tax Considerations in the Prospectus Supplement and Description of Debt
Securities in the Base Prospectus.
|
|
|
Exhibit No. |
|
Exhibit Description |
|
|
4.1 |
|
Indenture, dated as of November 20, 2009, between the Company and The Bank of New York Mellon Trust Company, N.A. (incorporated herein by reference to Exhibit 99.1 to the Companys Current Report on Form 8-K filed with the SEC
on November 20, 2009 (File No. 001-08002)). |
|
|
4.2 |
|
Tenth Supplemental Indenture, dated as of November 24, 2015, among the Company, The Bank of New York Mellon Trust Company, N.A, as trustee, and The Bank of New York Mellon, London Branch, as paying agent, including form of the Note
(incorporated herein by reference to Exhibit 4.2 to the Companys Current Report on Form 8-K filed with the SEC on November 24, 2015 (File No. 001-08002)) |
|
|
4.3 |
|
Paying Agency Agreement, dated as of November 24, 2015, between the Company and The Bank of New York Mellon, London Branch (incorporated herein by reference to Exhibit 4.3 to the Companys Current Report on Form 8-K filed with
the SEC on November 24, 2015 (File No. 001-08002)) |
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration
statement to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
|
THERMO FISHER SCIENTIFIC INC. |
|
|
By: |
|
/s/ Seth H. Hoogasian |
Name: |
|
Seth H. Hoogasian |
Title: |
|
Senior Vice President, General Counsel and
Secretary |
Dated: November 24, 2015
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Sep 2023 to Sep 2024